Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Competent and willing to voluntarily provide informed consent~* 18 years of age or older~* In good general health needing to undergo cataract extraction or lens extraction with lens replacement surgery in one eye, under topical anesthesia~Exclusion Criteria:~* No allergies to the medications and/or the active ingredients of any of the study medications~* No medications with the same activities of the active ingredients in OMS302 for defined time intervals prior to and after surgery~* No other significant eye injuries, eye conditions or general medical conditions likely to interfere with the evaluation of the study medication

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- OMS302 (Type: EXPERIMENTAL): OMS302 diluted in Balanced Salt Solution and administered as irrigation solution during Intraocular Lens Replacement surgery.
- Placebo (Type: PLACEBO_COMPARATOR): Placebo diluted in Balanced Salt Solution and administered as irrigation solution during Intraocular Lens Replacement surgery.

Based on this trial design, predict the completion outcome and termination type (if applicable).